Tuberculosis and Respiratory Diseases

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission

Narongwit Nakwan, Thidarat Ruklerd, Pattarawadee Taptawee

Tuberc Respir Dis. 2022;85(3):227-236. Published online May 30, 2022
DOI: https://doi.org/10.4046/trd.2022.0038

A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission

Narongwit Nakwan, Thidarat Ruklerd, Pattarawadee Taptawee

Tuberculosis and Respiratory Diseases. 2022;85(3):227-236

Link1

Link2 Link3

Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma

S.K. Willsie

Yearbook of Pulmonary Disease. 2008;2008:52-54

Link1 Link2

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial

Jenish J Arun, Rakesh Lodha, Sushil K Kabra

BMC Pediatrics. 2012;12(1):

Link1

Link2 Link3 Link4

A randomized, double-blind trial on the effect of treatment with montelukast, budesonide, montelukast with budesonide, formoterol with budesonide on lung function and clinical symptoms in children with asthma

I. Stelmach, T. Grzelewski, J. Jerzynska, P. Kuna

Journal of Allergy and Clinical Immunology. 2005;115(2):S151

Link1 Link2

Treatment with 400 μg of inhaled budesonide vs 200 μg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial

Gokul C. Jat, Joseph L. Mathew, Meenu Singh

Annals of Allergy, Asthma & Immunology. 2006;97(3):397-401

Link1 Link2

Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial

Akash Balki, S. Balamurugan, Suhas Bardapurkar, Sonia Dalal, Ajeet Singh, B.P. Singh, Abhijit Vaidya, Jaideep A. Gogtay

Pulmonary Pharmacology & Therapeutics. 2018;48:28-36

Link1 Link2

Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma

P. Kuna, J.P.H.M. Creemers, V. Vondra, P.N. Black, A. Lindqvist, U. Nihlen, C. Vogelmeier

Respiratory Medicine. 2006;100(12):2151-2159

Link1 Link2

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial

S.K. Willsie

Yearbook of Pulmonary Disease. 2012;2012:18-19

Link1 Link2

James Zangrilli, Lyndon E. Mansfield, Tom Uryniak, Christopher D. O'Brien

Annals of Allergy, Asthma & Immunology. 2011;107(3):258-265.e2

Link1 Link2

Adjustable maintenance dosing with budesonide/formoterol (Symbicort®) reduces treatment costs in asthma

P.W. Ind, B. Ställberg, S.N. Willich

International Journal of Clinical Practice. 2004;58:33-41

Link1 Link2